Securities Litigation

Subscribe to Securities Litigation via RSS

For several years now, one of the perennial questions in the corporate and securities arena has been the extent to which cybersecurity-related issues will contribute to D&O claims. There has never really been the volume of securities and derivative lawsuits that some observers expected, but there has been a small scattering of occasional suits filed from time to time. Now, in what is the latest cybersecurity-related D&O suit, a plaintiff shareholder has filed securities class action lawsuit against pay-TV services provider, Dish Networks, related to a network service disruption at the company caused by a cyber-security incident. A copy of the March 23, 2023, complaint can be found here.Continue Reading Dish Networks Hit with Cybersecurity-Related Securities Suit

At the beginning of the year, when I surveyed the D&O claims landscape and predicted the factors that I thought might drive D&O claims volume in 2023, one set of factors I projected might make significant contributions to the number of claims to be filed during the year were the number of macroeconomic challenges – for example, rising interest rates, economic inflation, labor supply disruption, and the war in Ukraine. The recent failure of Silicon Valley Bank and the ensuing securities litigation provides one illustration of how these macro factors can translate into D&O claims.

Now, in the latest illustration of these forces at work, investors have filed a securities lawsuit against the organic foods company United Natural Foods, following the company’s recent disappointing earnings announcement in which the company disclosed a decline in profitability, despite increasing sales, due to inflationary pressures. A copy of the March 20, 2023, lawsuit against United Natural Foods can be found here.Continue Reading Inflation Hits Organic Food Company’s Quarterly Results, Draws Securities Suit

The opioid crisis in the United States is not a new development; sadly, it has been around for years, as has D&O litigation relating to the crisis. Indeed, more than five years ago, I published a post in which I noted the outbreak at the time of a number of opioid-related securities suits. Now, in the latest of these opioid-related securities suits to be filed, and in the wake of the U.S. Department of Justice’s filings of a complaint in intervention in an opioid-related False Claims action against the company, a securities class action lawsuit has now been filed against the pharmacy company, Rite Aid Corporation. The March 20, 2023, Rite Aid complaint can be found here.Continue Reading Rite Aid Hit with Opioid-Related Securities Suit

       

The securities class action lawsuits filed last week against failing or troubled banks felt as if the plaintiffs’ attorneys filing the suits were typing their complaints directly from the text of the day’s newspapers. Another suit filed last week referred to a slightly earlier but even more dramatic news story, the tragic train derailment in East Palestine, Ohio, of a Norfolk Southern freight train. The events surrounding the train disaster undoubtedly will be the subject of personal and environmental lawsuits for years to come. Now, the high-profile event is also the subject of a securities class action lawsuit, in the most recent example of the ways that operational events, rather than financial disclosures, increasingly can lead to securities litigation. A copy of the March 16, 2023, complaint can be found here.Continue Reading Ripped from the Headlines: Norfolk Southern Hit with Securities Suit      

Scott Schechter
Paul Curley

Readers will recall that month when Cornerstone Research issued its annual report on securities class action lawsuit filings, the report showed that the number of crypto-related securities suits had soared, with 21 crypto-related suits filed in 2022, compared to only 11 in 2021. In the following guest post, Scott Schechter and Paul Curley take a look at this emerging new trend in securities class action lawsuit filings involving cryptocurrency and other digital asset-related securities suits. Scott and Paul are Partners in Kaufman Borgeest & Ryan’s Coverage Group in New York. I would like to thank Paul and Scott for allowing me to publish their article as a guest post on this site. I welcome guest post submissions from responsible authors on topics of interest to this blog’s readers. Please contact me directly if you would like to submit a guest post. Here is Paul and Scott’s guest post.Continue Reading Guest Post: Crypto is the New Frontier in Securities Fraud Litigation

Earlier this week, securities class action lawsuits were filed against the recently failed U.S. banks, Silicon Valley Bank and Signature Bank. The turmoil that surrounded those banks’ failure sent ripples into the global banking industry; one of the institutions particularly affected by the ensuing turbulence was the European banking giant, Credit Suisse. After a series of events at the bank earlier this week (described below), the company’s share price tanked, the Swiss banking regulator extended the bank a financial lifeline – and the bank was hit with a securities class action lawsuit, the third this week involving a bank caught up in the sudden wave of banking industry disorder. The new lawsuit filed on March 16, 2023, against Credit Suisse can be found here.Continue Reading Now It’s Credit Suisse’s Turn: Swiss Bank Hit with Securities Suit

By Monday morning of this week, two banks had failed in quick sequence, including the very high-profile collapse last week of Silicon Valley Bank (SVB) and the closure over the weekend of Signature Bank. SVB got hit with a securities class action lawsuit yesterday, so what had to happen next? Why, a securities suit against Signature Bank, of course. On Tuesday morning, the same plaintiffs’ law firm that sued SVB on Monday filed a separate securities class action lawsuit against Signature Bank and three of its executives. How much further any of this goes from here is the question on everyone’s minds. A copy of the Signature Bank complaint can be found here.Continue Reading SVB Got Sued, So, What Next? A Suit Against Signature Bank, Of Course

The total number of securities class action lawsuit settlements reached the highest level in 15 years in 2022, and median, average, and aggregate settlement amounts also rose significantly in 2022 compared to the year prior, according a recently published annual report from Cornerstone Research. The report, entitled “Securities Class Action Settlements: 2022 Review and Analysis,” analyzes the 105 securities class action lawsuit settlements finalized in 2022 and compares them statistically with prior years’ settlements. The report can be found here. Cornerstone Research’s March 8, 2023, press release about the report can be found here.Continue Reading Cornerstone Research: Securities Suit Settlements at High Levels in 2022

In my year-end wrap up of the top D&O stories of 2022, I noted the possibilities that various macroeconomic factors could contribute to securities class action lawsuit filings in the months ahead. One of the specific factors I identified was economic inflation. In subsequent conversations, I have been asked how an economy-wide phenomenon such as inflation could lead to a securities suit against any one individual company. A lawsuit filed earlier this week provides an illustration of how the inflationary impacts can translate into securities litigation. A copy of the March 1, 2023 complaint in the lawsuit, filed against coffee retailer and franchisor Dutch Bros Inc., can be found here.Continue Reading Inflation Undercuts Company’s Financial Results, Leads to Securities Suit

The number of securities class action lawsuits filed against life sciences companies in 2022 declined compared to 2021 but remained relatively steady as a proportion of the total number of securities class action lawsuits filed during the year, according to a new report from the Dechert law firm. The report, entitled “Dechert Survey 2022 Edition: Developments in Securities Fraud Class Actions Against U.S. Life Sciences Companies,” states that there were a total of 43 securities suits filed against life sciences companies in 2022, compared to 59 in 2021. The Dechert law firm’s February 23, 2023 press release about the report, which links to the full report,  can be found here.Continue Reading Life Sciences Companies Remained Frequent Securities Suit Targets in 2022